Tag Archives: Michiel Tack

MAGENTA trial comment: ‘Targeting activity levels in ME/CFS

Michiel Tack queries some conclusions of the recently published MAGENTA trial paper. Physical activity patterns among children and adolescents with mild-to-moderate chronic fatigue syndrome/myalgic encephalomyelitis, by Emma Solomon-Moore, Russell Jago, Lucy Beasant, Amberly Brigden, Esther Crawley in BMJ Paediatrics Open … Continue reading

Posted in News | Tagged , , , , , , , , , , , | Comments Off on MAGENTA trial comment: ‘Targeting activity levels in ME/CFS

Why GET and CBT are controversial in CFS

Why Graded Exercise Therapy and Cognitive Behaviour Therapy are controversial in Chronic Fatigue Syndrome, by Michiel Tack in BMJ Medical Humanities blog Sharpe and Greco ask the interesting question of why cognitive behaviour therapy (CBT) and graded exercise therapy (GET) … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Why GET and CBT are controversial in CFS

The risk of labelling CFS symptoms as unhelpful cognitive responses

The risk of labelling CFS symptoms as unhelpful cognitive responses, by Michiel Tack in Clinical Child Psychology and Psychiatry 1–2 [Published June 18, 2019]  https://doi.org/10.1177/1359104519853849   Letter to the editor: Loades, M. E., Rimes, K., Lievesley, K., Ali, S., & … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on The risk of labelling CFS symptoms as unhelpful cognitive responses

Clinical symptoms & markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection

Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: an exploratory cross-sectional study, by Miriam Skjerven Kristiansen, Julie Stabursvik, Elise Catriona O’Leary, Maria Pedersen, Tarjei Tørre Asprusten, Truls Leegaard, Liv Toril Osnes, Trygve Tjade, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on Clinical symptoms & markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection